COMPANIES

symjepi

EpiPen alternative Symjepi could launch as early as this year

U.S. Food and Drug Administration (FDA) gave its stamp of approval to Adamis Pharmaceuticals Corp.'s Symjepi - an alternative to the expensive EpiPen. The approval...

INDUSTRY

FINANCE

HIV AIDS

Financial incentives can motivate some HIV patients to take HIV antiretroviral...

Researchers have found that offering financial incentives can motivate some HIV patients to take up HIV antiretroviral therapy (ART) medication regularly and maintain viral...

MARKET

Foreign Currency

Qatar riyal under no threat of devaluation

The recent diplomatic crisis is affecting Qatar's riyal with the currency being quoted weaker than its peg against the dollar, but experts are of...